“Thrombosis is the most feared complication of cardiovascular diseases and a main cause of death worldwide, making it a major health-care challenge. Platelets and the coagulation cascade are effectively targeted by antithrombotic approaches, which carry an inherent risk of
bleeding. Moreover, antithrombotics cannot completely prevent thrombotic events, implicating
a therapeutic gap due to a third, not yet adequately addressed mechanism, namely inflammation.”